- Docket No.
- 0:23-cv-02024
- District Court
- Minnesota
Goal
- Enjoin enforcement of law
- Invalidate state law
Issues
Case History
Litigation Content
Why this Matters
The plaintiff argues that a Minnesota law prohibiting generic drug manufacturers from excessively increasing prices violates the Due Process Clause of the Fourteenth Amendment as well as the Dormant Commerce Clause. Price gouging laws are one approach states are currently pursuing to lower prescription drug costs for their residents.
Potential Impact
The inability for state policymakers to address prescription drug affordability could negate savings for patients, and more broadly restrict state regulatory authority in the health care arena.
10 Major Filings
- ORDER GRANTING STAY OF DISTRICT COURT PROCEEDINGS PENDING APPEAL (Jan 4, 2024)
- DEFENDANT'S NOTICE OF APPEAL (Jan 2, 2024)
- JUDGMENT (Dec 4, 2023)
- ORDER GRANTING PRELIMINARY INJUNCTION (Dec 4, 2023)
- REPLY IN SUPPORT OF DEFENDANT'S MOTION TO DISMISS (Aug 23, 2023)
- REPLY IN SUPPORT OF MOTION FOR PRELIMINARY INJUNCTION AND OPPOSITION TO MOTION TO DISMISS (Aug 11, 2023)
- DEFENDANT'S MOTION TO DISMISS (Jul 31, 2023)
- MEMORANDUM OF LAW IN SUPPORT OF PLAINTIFF'S MOTION FOR PRELIMINARY INJUNCTION (Jul 19, 2023)
- PLAINTIFF'S MOTION FOR PRELIMINARY INJUNCTION (Jul 19, 2023)
- COMPLAINT (Jul 5, 2023)